News|Articles|February 2, 2024

AJMC® in the Press, February 2, 2024

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from MedCityNews referenced an article published on AJMC.com, the website of The American Journal of Managed Care^®. The article, “Innovation in Value-Based Care Requires More Data, Patient-Centered Thinking,” was a part of conference coverage for Patient-Centered Oncology Care^®. The article related information on a panel discussion that focused on the Enhancing Oncology Model and the movement toward value-based care in oncology.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related to this article

October 24th, 2026

One-Size Dialysis Volume Goals Fall Short in CKD: Jennifer Flythe, MD

Jennifer Flythe, MD, MPH, discusses individualizing dialysis volume management and why guideline-directed therapy use lags in advanced CKD.

Adults with IgA nephropathy who received povetacicept had a 52.0% reduction in proteinuria at week 36 compared with 4.3% with placebo in the phase 3 RAINIER interim analysis. | Image credit: filins - stock.adpbe.com

October 24th, 2026

Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36

Povetacicept reduced proteinuria by 52% vs 4.3% with placebo at week 36 in adults with IgA nephropathy in the phase 3 RAINIER trial’s interim analysis.

A safety-net outpatient dialysis pathway for unfunded patients with ESKD cut monthly ED visits from 29.7 to 4.0 and lowered direct costs by 83%, data show. | Image credit: mailsonpignata - stock.adobe.com

October 24th, 2026

Dialysis Access, Church CKD Screening Address Kidney Care Inequities

Outpatient dialysis for unfunded patients with ESKD cut ED reliance and costs, while church-based CKD screening improved blood pressure.

globe health | Image credit: Tex vector - stock.adobe.com

October 24th, 2026

Expert Panel Updates Consensus on Mantle Cell Lymphoma Care Using Pan-Asian Data

Asian expert consensus updates mantle cell lymphoma treatment guidelines, highlighting uneven BTK inhibitor, ibrutinib and CAR T-cell access across Asia.

The KCC model raised optimal dialysis starts but cost Medicare $304.8 million in 2023. | Image credit: momius - stock.adobe.com

October 24th, 2026

Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care

At ASN Kidney Week 2026, nephrologists said value-based kidney models improved dialysis starts, but payment cuts and MA growth are pushing practices out.